Basic approaches and evidence base
The primary patient population for radiation therapy consists of patients with muscle-invasive bladder cancer. At the initial or general stages of treatment, the total tumor dose (TTD) typically ranges within 20–45 Gy.
The main objectives of this stage are:
- Maximum reduction in the degree of malignant tumor invasion.
- Prevention of potential local recurrence after surgical intervention.
It should be noted that the evidence base for this approach is not absolute: the recommendation grade is rated as C, and the level of evidence is 4. Within the professional community, data remain contradictory: some studies demonstrate a real reduction in the number of local recurrences, while other authors find no statistically significant effect of irradiation on recurrence rates and overall patient survival.
Postoperative radiation therapy
In the postoperative period, radiotherapy is prescribed with a strictly prophylactic purpose—to prevent disease recurrence. Unlike the previous point, here the clinical picture is supported by a higher evidence base (recommendation grade A, level of evidence 2).
Therapy is indicated in the presence of the following factors:
- Locally advanced form of the disease (stage pT3–4).
- Detection of a positive surgical margin (R+), which indicates the presence of residual tumor cells.
External beam radiotherapy protocols
The technique of external beam radiotherapy is based on classical fractionation—sessions are conducted 5 times a week with a fraction dose of 2 Gy. The strategy depends on the status of regional lymph nodes (LNs).
1. Standard protocol (targeting the tumor bed):
- First stage: irradiation of the removed tumor bed up to a TTD of 50 Gy.
- Second stage (boost): local additional irradiation of the residual tumor area up to a TTD of 10–16 Gy.
- Total dose: 60–66 Gy.
2. Protocol for metastatic lymph node involvement:
- First stage: irradiation of the regional bladder LNs up to a TTD of 50 Gy.
- Second stage: targeted local boost to metastatic LNs (verified by CT data) up to a TTD of 16 Gy.
- Total dose: 66 Gy.
Specific complications: Following surgical removal of the bladder, topographo-anatomical relationships in the lesser pelvis change. Bowel loops descend into the irradiation zone, which naturally leads to an increased incidence of post-radiation gastrointestinal complications.
Technical equipment and brachytherapy
In extensive locally advanced disease, particularly when the tumor process invades adjacent structures (e.g., involvement of the uterine cervix), a standard applicator is insufficient. To precisely optimize the dose distribution within the target volume, interstitial needles are additionally used.
The brachytherapy course usually fits into 3–4 fractions. Although the classical Point A traditionally serves as a landmark for dosimetric optimization, modern reporting and plan quality assessment are performed exclusively based on volumetric dose distribution.
Target dose parameters (assuming a baseline delivery of 45 Gy via external beam therapy):
- Isolated brachytherapy: equivalent to 40–45 Gy ($EQD2$).
- CTV-THR (high-risk volume, full course): 85–90 Gy ($EQD90$).
- CTV-TIR (intermediate-risk volume): ≥60 Gy ($D98$).
- GTV-Tres (residual tumor): ≥90 Gy ($D98$).
Organs at risk (OAR) constraints
Dosimetric planning requires strict control of the radiation load on healthy tissues. The main criterion is the D2cc parameter, which is the minimum dose received by the most irradiated 2 cm³ volume of a specific organ.
Maximum permissible values ($EQD2_3$):
- Bladder: < 80–90 Gy.
- Rectum: < 65–75 Gy.
- Sigmoid colon: < 70–75 Gy.
- Bowel loops: < 70–75 Gy.
- Rectovaginal area (vagina): < 65–75 Gy.
To memorize the basic EBRT protocol: "50 to the base, 16 to the residue — total 66". This reflects 50 Gy to the bed or lymph nodes and a 16 Gy boost to the residual tumor.
Class and exam questions
In which cases is postoperative radiation therapy strictly indicated?
The procedure is indicated for patients with muscle-invasive cancer at stages pT3–4, as well as in cases of a positive surgical margin (R+) to prevent local recurrence.
What is the main cause of increased gastrointestinal complications after cystectomy?
After radical bladder removal, the anatomy of the lesser pelvis changes: bowel loops shift downward and fall into the active irradiation field, which increases the risk of radiation-induced mucosal injury.
What does the D2cc parameter mean when assessing organs at risk?
D2cc is a dosimetric parameter indicating the minimum dose absorbed by the most irradiated organ volume measuring exactly 2 cubic centimeters. It is critical for preventing radiation ulcers and strictures.
How is the efficacy of preoperative treatment evaluated?
Data on preoperative irradiation are contradictory (grade C). Some specialists note a reduction in the degree of invasion and the number of recurrences, while others see no improvement in survival rates.
What else to study on this topic
- Radiobiological rationale for equivalent dose (EQD2) and fractionation calculation.
- Principles of CTV-THR, CTV-TIR, and GTV-Tres volume contouring according to international standards.
- Physical and technical features of interstitial needle placement in locally advanced pelvic tumors.
- Methods for preventing radiation-induced enteritis and colitis.
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete guide on "Radiation therapy of bladder tumors" and 2,199 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Other topics in the "Additional Topics" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.